Bezlotoxumab (Zinplava) for Clostridium Difficile Infection: The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial Infection.

Bezlotoxumab (Zinplava) to prevent the recurrence of Clostridium difficile infection.